MAPK3 and hepatocellular carcinoma: Additionally, CPE treatment of hepatocellular carcinoma (HCC) MHCC97H cells during metabolic stress has been shown to mediate survival by up-regulating anti-apoptotic protein BCL-2 and other pro-survival genes through activation of the ERK1/2 pathway [19].